Premium biological intermediates selected for the emerging biochemical and therapeutic development centers in Malaysia.
Kuala Lumpur, as the beating heart of Malaysia’s economic modernization, has quietly transformed from an administrative and financial nucleus into a highly sophisticated regional hub for biotechnology, pharmaceutical manufacturing, and advanced animal health sciences. Backed by the Malaysian Government's National Biotechnology Policy 2.0 (NBP 2.0) and strategic developments within the Klang Valley, the demand for highly specialized biochemical substrates has surged exponentially. Among these critical compounds, the Cholic Acid Series Products have taken center stage as indispensable starting materials, active pharmaceutical ingredients (APIs), and formulations enhancers.
The local industrial demand in Kuala Lumpur and its surrounding industrial corridors (such as Shah Alam, Petaling Jaya, and Cyberjaya) spans across multiple high-value sectors:
Understanding the exact thermodynamic behavior and physiological interactions of cholic acid derivatives is critical for formulators. The cholic acid series represents a family of C24 steroid molecules synthesized in the liver from cholesterol. The primary components exported to the Kuala Lumpur pharmaceutical market include:
Serves as key industrial precursors for the chemical synthesis of Ursodeoxycholic Acid (UDCA). Deoxycholic acid is widely utilized in cosmetic lipolysis formulations and biochemical cell-lysis detergents.
Highly effective hydrophilic bile acids. TUDCA prevents mitochondrial cell death pathway activation, offering neuroprotective qualities in clinical studies and treating cholestatic liver diseases.
Sodium Taurochenodeoxycholate and Sodium Deoxycholate exhibit high water-solubility and act as potent surfactants in biological assays and industrial emulsion polymerization.
Through their interaction with the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor (TGR5), these compounds regulate systemic lipid, glucose, and energy homeostasis. As exporters to the Kuala Lumpur market, we strictly maintain batch-to-batch consistency, ensuring HPLC purities exceeding 98.5% with minimal heavy metal contamination (< 10ppm), fulfilling the highest standards set by the United States Pharmacopeia (USP) and European Pharmacopoeia (EP).
For international procurement departments sourcing active ingredients for Kuala Lumpur’s pharmaceutical plants, raw material quality assurance is not merely a preference; it is a critical regulatory gatekeeper. The National Pharmaceutical Regulatory Agency (NPRA) of Malaysia mandates strict compliance with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP guidelines. Our supply chain infrastructure is designed to seamlessly integrate with these requirements.
Key checkpoints resolved by our export protocols include:
Our logistics network is optimized for shipments into Port Klang and Kuala Lumpur International Airport (KLIA), utilizing temperature-controlled container setups to preserve chemical structure integrity and prevent hydrolysis or degradation during transit.
Chengdu ChenLv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
By integrating green chemical engineering principles with state-of-the-art purification technology, Chenlv Herb is dedicated to becoming a primary strategic partner for biomedical research institutions and commercial pharmaceutical manufacturers globally, especially within the thriving markets of Southeast Asia.
Learn More About Our Factory
Delivering biological extracts and synthetic derivatives that exceed global standard requirements.
Creative designs and molecular structures that elevate your brand and clinical outcomes.
Eco-friendly packaging and optimized industrial synthesis aligned with today’s green chemistry values.
End-to-end cosmetic packaging and bio-extraction solutions that satisfy rigorous ESG demands.
Fast turnaround times and direct real-time tracking to meet your tight manufacturing timelines.
A dedicated expert QC team supporting you with analytical documentation every step of the way.
Years of industrial expertise ensuring synthesis precision and operational excellence in export logistics.
From therapeutic pharmaceutical pathways to animal growth optimization, discover the practical uses of our compounds.
Driven by the concept of "homology of medicine and food" and modern health needs, plant and bile extracts have become core raw materials for natural health supplements.
From historical remedies to advanced novel drugs, plant extracts and bile acid compounds maintain structural priority due to their highly stable pharmacological mechanisms.
With growing demand for natural, safe, and biocompatible ingredients, bile acid derivatives like deoxycholates are key in local fat-dissolving and facial aesthetic treatments.
Cholic acid additives show remarkable potential in improving lipid digestion, optimizing feed absorption ratios, and supporting liver and gut integrity in aquaculture.
How we partner with Kuala Lumpur buyers to deliver tailored molecular purities and special packaging forms.
Click below to browse specific structures, download technical data sheets (TDS), and obtain quick quotes.
As sustainability regulations intensify globally and within Malaysia's Green Technology Master Plan, the traditional extraction of cholic acid from animal bile is undergoing a massive shift. Our R&D facility is at the forefront of this transformation. We are currently implementing a dual-track development roadmap:
By investing in these advanced technological pathways, we guarantee that our supply partner network in Kuala Lumpur remains ahead of international environmental mandates, securing long-term market access and building high-trust consumer relations.
Our operations and raw materials adhere to strict international standards for absolute reliability.
Stay informed about our upcoming global exhibition participation and deep insights into the biochemical raw materials market.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end and new supplies gradually enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to present the latest breakthroughs in biochemical and API synthesis.
The 92nd China International Pharmaceutical Raw Materials / Intermediates / Packaging / Equipment Fair (API China) will grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou from May 21-23, 2025. Explore our complete Cholic Acid Series derivatives live.
Get professional, direct answers regarding our export capabilities and technical specifications for the Kuala Lumpur market.
Connect directly with our senior product directors to obtain customized purity configurations, bulk pricelists, and specific compliance certificates tailored for the Kuala Lumpur pharmaceutical market.
Send Inquiry Now
Chenlv Herb
